Advertisement

Topics

Shire wins U.S. approval for long-acting ADHD drug

00:40 EDT 21 Jun 2017 | Reuters

(Reuters) - Shire has won U.S. approval for a long-acting attention deficit drug aimed at adolescents and adults, boosting its stock of medicines for the cognitive condition that affects millions of children and is being diagnosed more in older peopl...

Original Article: Shire wins U.S. approval for long-acting ADHD drug

NEXT ARTICLE

More From BioPortfolio on "Shire wins U.S. approval for long-acting ADHD drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...